Exploiting the potential of the ubiquitin-proteasome system in overcoming tyrosine kinase inhibitor resistance in chronic myeloid leukemia

The advent of tyrosine kinase inhibitors (TKI) targeting BCR-ABL has drastically changed the treatment approach of chronic myeloid leukemia (CML), greatly prolonged the life of CML patients, and improved their prognosis. However, TKI resistance is still a major problem with CML patients, reducing th...

詳細記述

書誌詳細

出版年:	Genes and Diseases
主要な著者:	Xudong Li, Wei Li, Yanli Zhang, Linping Xu, Yongping Song
フォーマット:	論文
言語:	英語
出版事項:	KeAi Communications Co., Ltd. 2024-09-01
主題:	Chronic myeloid leukemia Deubiquitinases E3 ligase PROTAC TKI resistance Ubiquitin-proteasome system
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2352304223004336